April 12, 2021
Community Shares:
- The FDA just approved an ADHD medication for children ages 6 to 17 that is neither a stimulant nor a controlled substance. In a late-stage study funded by the manufacturer, the drug, Qelbree, reduced inattention and hyperactivity by 50% in research participants. However, Qelbree does carry a warning for potential suicidal thoughts and behavior, which occurred in less and 1% of the study’s volunteers.
- In recognition of Autism Awareness Month, ARI is sharing a list of resources on a specialized autism topic each month. This week they focus on nutrition and gastrointestinal disorders.
- A TV station in San Antonio, Texas featured a list of celebrities that have been previously diagnosed with autism.
- The Conte Center at UC Davis received a $15 million grant from the National Institute of Mental Health to investigate the effects of maternal infections on offspring.
- Spectrum magazine recently examined the changes that occur in the brains of children with autism when they go through puberty.
